X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (25) 25
index medicus (25) 25
oncology (25) 25
male (24) 24
surgery (18) 18
animals (17) 17
cancer (15) 15
female (15) 15
mice (14) 14
immunology (13) 13
middle aged (12) 12
adult (11) 11
immunotherapy (11) 11
mice, inbred c57bl (11) 11
aged (10) 10
t-lymphocytes - immunology (10) 10
dendritic cells - immunology (9) 9
pancreatic cancer (9) 9
immunohistochemistry (8) 8
lymphocytes (8) 8
metastasis (8) 8
mice, inbred balb c (8) 8
in-vivo (7) 7
prognosis (7) 7
spleen - immunology (7) 7
t cells (7) 7
t-cells (7) 7
aged, 80 and over (6) 6
analysis (6) 6
care and treatment (6) 6
chemotherapy (6) 6
dendritic cells - metabolism (6) 6
immunity (6) 6
liver - immunology (6) 6
lymphocyte activation (6) 6
lymphocyte activation - immunology (6) 6
neoplasm staging (6) 6
spleen - cytology (6) 6
survival (6) 6
antigen (5) 5
article (5) 5
dendritic cells - cytology (5) 5
diagnosis (5) 5
killer cells, natural - immunology (5) 5
liver - cytology (5) 5
liver neoplasms - secondary (5) 5
liver neoplasms - surgery (5) 5
lymphocytes, tumor-infiltrating - immunology (5) 5
medicine & public health (5) 5
mouse-liver (5) 5
pancreatic neoplasms - immunology (5) 5
retrospective studies (5) 5
survival rate (5) 5
tumors (5) 5
young adult (5) 5
abridged index medicus (4) 4
activation (4) 4
adenocarcinoma (4) 4
antigen presentation (4) 4
carcinoma, pancreatic ductal - pathology (4) 4
colorectal-cancer (4) 4
dendritic cells (4) 4
follow-up studies (4) 4
gastroenterology & hepatology (4) 4
hepatocellular-carcinoma (4) 4
immune cells (4) 4
immunophenotyping (4) 4
liver neoplasms - immunology (4) 4
metastases (4) 4
multidisciplinary sciences (4) 4
pancreatic neoplasms - pathology (4) 4
pancreatic neoplasms - therapy (4) 4
progression (4) 4
research (4) 4
research article (4) 4
surgical oncology (4) 4
t-lymphocytes - metabolism (4) 4
therapy (4) 4
time factors (4) 4
adenoviridae - immunology (3) 3
apoptosis (3) 3
biology and life sciences (3) 3
carcinoma (3) 3
carcinoma, pancreatic ductal - immunology (3) 3
cd4-positive t-lymphocytes - immunology (3) 3
cell biology (3) 3
cell count (3) 3
cell proliferation (3) 3
cells, cultured (3) 3
colorectal neoplasms - pathology (3) 3
combined modality therapy (3) 3
cytotoxicity, immunologic (3) 3
expression (3) 3
flow cytometry (3) 3
hemic and immune systems (3) 3
heterogeneity (3) 3
ifn-gamma (3) 3
immune response (3) 3
immune tolerance (3) 3
impact (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 616 - 616
Journal Article
OncoImmunology, ISSN 2162-4011, 08/2014, Volume 3, Issue 8, p. e950171
Recent studies of human pancreatic cancer challenge the mouse model-derived notion that the pancreas is a site of immune privilege. A heavy infiltration of CD8... 
regulatory T cells | myeloid cells | IDO | PD-1 | immune checkpoints | Myeloid cells | Immune checkpoints | Regulatory T cells | ONCOLOGY | IMMUNOLOGY
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 06/2017, Volume 127, Issue 6, pp. 2176 - 2191
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 2957 - 2957
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96565
Objective: The immune response to pancreatic ductal adenocarcinoma (PDA) may play a role in defining its uniquely aggressive biology; therefore, we sought to... 
MULTIDISCIPLINARY SCIENCES | BONE-MARROW | PERIPHERAL-BLOOD | SUPPRESSOR-CELLS | CANCER | CARCINOMA | T-CELLS | TUMOR MICROENVIRONMENT | GEMCITABINE | CLINICAL-SIGNIFICANCE | TH17 CELLS | Adenocarcinoma - pathology | CD8-Positive T-Lymphocytes - pathology | Humans | Middle Aged | Interleukin-17 - immunology | Male | Antineoplastic Agents - therapeutic use | CD4-Positive T-Lymphocytes - pathology | T-Lymphocytes, Regulatory - pathology | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | Aged, 80 and over | Adult | Female | Carcinoma, Pancreatic Ductal - immunology | Tumor Microenvironment - drug effects | Adenocarcinoma - immunology | Pancreas - drug effects | Pancreas - pathology | Pancreas - immunology | Adenocarcinoma - drug therapy | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - drug therapy | T-Lymphocytes, Regulatory - drug effects | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Neoadjuvant Therapy - methods | Aged | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | CD4-Positive T-Lymphocytes - drug effects | Adenocarcinoma | Immunohistochemistry | Interferon | T cells | Comparative analysis | Flow cytometry | Therapy | Animal models | CD8 antigen | Helper cells | Effector cells | Systematic review | Lymphocytes T | Metastasis | Immunity | Cancer therapies | Blood | Metastases | Immunology | Lymphocytes | Surgery | Pancreas | Immune system | Medical research | Immunological memory | Memory cells | Myeloid cells | Immune response | Cell survival | Immunoregulation | Stroma | Inflammation | Survival | Interleukin 17 | Hemopoiesis | CD4 antigen | Medicine | Studies | Pathology | Cytometry | Immunosuppression | Chemotherapy | Medical prognosis | γ-Interferon | Pancreatic cancer | Infiltration | Evolution & development | Tumors | Apoptosis
Journal Article
Cancer, ISSN 0008-543X, 09/2017, Volume 123, Issue 17, pp. 3291 - 3304
To the author's knowledge, the current study provides the most comprehensive characterization of the sarcoma tumor immune microenvironment to date through the... 
leiomyosarcoma | sarcoma | pleomorphic | programmed death‐ligand 1 (PD‐L1) | T‐cell receptors | immunotherapy | liposarcoma | gene expression | programmed cell death protein (PD‐1) | T-cell receptors | programmed cell death protein (PD-1) | programmed death-ligand 1 (PD-L1) | NY-ESO-1 | PAZOPANIB | DOXORUBICIN | CANCER | TRIAL | ONCOLOGY | EUROPEAN-ORGANIZATION | BLOCKADE | LYMPHOCYTES | Immunohistochemistry | Prognosis | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Sarcoma - therapy | Young Adult | Neoplasm Invasiveness - pathology | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Clone Cells | Retrospective Studies | Sarcoma - genetics | Soft Tissue Neoplasms - genetics | Databases, Factual | Soft Tissue Neoplasms - therapy | Soft Tissue Neoplasms - mortality | Combined Modality Therapy | Sarcoma - pathology | Disease-Free Survival | Analysis of Variance | T-Lymphocytes - cytology | Soft Tissue Neoplasms - pathology | Survival Analysis | T-Lymphocytes - immunology | Aged | Biopsy, Needle | Neoplasm Staging | Programmed Cell Death 1 Receptor - genetics | Cluster Analysis | Cohort Studies | Care and treatment | Sarcoma | Cell death | Analysis | Research | Diagnosis | Gene expression | PD-1 protein | Identification methods | Lymphocytes T | Paraffin | Formaldehyde | Metastases | Gene sequencing | T-cell receptor | Immunotherapy | Immune system | Antigen presentation | Antigens | Immune response | Synovial sarcoma | Mortality | Soft tissue sarcoma | Autoantigens | Inflammation | T cell receptors | Patients | Immune checkpoint | Immunogenicity | PD-L1 protein | Liposarcoma | Ligands | Infiltration | Cancer | Tumors | Apoptosis | Original
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 3/2013, Volume 20, Issue 3, pp. 946 - 955
Journal Article